EYE Flashcards

1
Q

Bacterial Conjunctivitis

A
  • What is it:

“inflammation of the conjunctival tissue, engorgement of blood vessels, pain, ocular discharge
can be chronic or acute and infectious or non-infectious”

  • Etiology/Pathogens:

s. aureus, s. pneumoniae, h. influenza, c. trachomatis

  • Epidemiology:

december to april peak, more prevalent in children

  • Pathophysiology:

“transmission of pathogens into the conjunctiva either of bacterial or viral origin
in allergic an allergen has contact with the ocular surface”

  • Signs:

purulent discharge, may be unilateral, conjunctival injection

  • History/Symptoms:

typically exposed from someone else, not washing hands

  • Evaluation:

“chlamydial - giemsa stain
neisseria - gram stain”

  • Treatment:

“0.5 inch of ointment deposited inside the lower lid or 1-2 drops instilled 4x a day for 5-7 days
erythromycin opthalmic ointment
trimethoprim and polymyxin B”

  • Patient Education:

wash hands, stop wearing contact lenses, safe sex (if STI), transmission prevention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Viral Conjunctivitis

A
  • What is it:

“inflammation of the conjunctival tissue, engorgement of blood vessels, pain, ocular discharge
can be chronic or acute and infectious or non-infectious”

  • Etiology/Pathogens:

adenovirus, herpes simplex, herpes zoster, enterovirus

  • Epidemiology:

usually in older children

  • Pathophysiology:

“transmission of pathogens into the conjunctiva either of bacterial or viral origin
in allergic an allergen has contact with the ocular surface”

  • Signs:

watery discharge, scant mucoid discharge, could be concurrent with an URI, preauricular lymphadenopathy

  • History/Symptoms:

swimming in pools can expose to adenovirus

  • Evaluation:

clinical evaluation diagnosis, but can use adenovirus tests

  • Treatment:

topical antihistamines or decongestants, warm or cool compresses, artificial tears

  • Patient Education:

washing hands to prevent transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
A
  • What is it:
  • Etiology/Pathogens:
  • Epidemiology:
  • Pathophysiology:
  • Signs:
  • History/Symptoms:
  • Evaluation:
  • Treatment:
  • Patient Education:
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cataract

A
  • What is it:

Clouding, opacification of the normally clear lens, can be bilateral and vary in severity

  • Etiology/Pathogens:

congenital, age-related, subcapsular (fibrous metaplasia), nuclear sclerotic, cortical, trauma, systemic diseases (myotonic, atopic dermatitis, neurofibromatosis type 2)

  • Epidemiology:

“white > black > hispanic
typically onset in 40-50s
more common in women”

  • Pathophysiology:

lens is made up of the cortex (superficial) and nucleus (deeper), degenerative processes denature and coagulate lens proteins

  • Signs:

decreased visual acuity, opacification of lens

  • History/Symptoms:

decrease or blurring vision, diplopia or polyplopia, colored halos around light, sensitivity to glare, increased frequence of changing glasses, disturbance in color vision

  • Evaluation:

visual acuity, cover and uncover test, pupillary response

  • Treatment:

“*lifestyle changes: glasses, brighter lights, anti-glare sunglasses
*pupillary dilatation with 2.5% phenylephrine
* cataract surgery”

  • Patient Education:

using visual acuity charts on a regular basis, wear spectacles in sunlight to avoid UV damage, systemic evaluation to rule out any systemic cause, refer to opthalmology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Scleritis

A
  • What is it:

inflammation of the sclera, categorized as diffuse, nodular, or necrotizing, unilateral or bilateral

  • Etiology/Pathogens:

“idiopathic, infectious, noninfectious
50% of patients will have an autoimmune condition, sometimes undiagnosed, commonly rheumatoid arthritis and systemic vasculitic conditions”

  • Epidemiology:

middle age (47-60), more common in women

  • Pathophysiology:

pathophys isn’t well understood, extracellular matrix is similar to that of joints which makes it susceptible in patient with rheumatoid arthritis

  • Signs:

ocular redness, pain on palpation of eyeball, visual impairment, no vessel blanching with phenylephrine, blue violet hue of deep vessels

  • History/Symptoms:

significant eye pain, worse at night, pain with eye movement, photophobia, tearing

  • Evaluation:

clinical presentation and ocular exam also need to screen for systemic disease that could be causing the scleritis

  • Treatment:

“*refer to opthalmologist
*topical corticosteroid eyedrops
*oral NSAIDs”

  • Patient Education:

explain risk of associated systemic conditions, pain management and control of inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Allergic Conjunctivitis

A
  • What is it:

“inflammation of the conjunctival tissue, engorgement of blood vessels, pain, ocular discharge
can be chronic or acute and infectious or non-infectious”

  • Etiology/Pathogens:

often secondary to other allergic reactions such as rhinitis

  • Epidemiology:

spring and summer peak, onset in those younger than 20 and decreases in old age

  • Pathophysiology:

“transmission of pathogens into the conjunctiva either of bacterial or viral origin
in allergic an allergen has contact with the ocular surface”

  • Signs:

itching, tearing, cobblestone mucosa, other allergic symptoms

  • History/Symptoms:

recurrent episodes, history of allergies

  • Evaluation:

clinical evaluation diagnosis, can use fluorescein staining to rule out abrasion can also use conjunctival scraping to examine eosinophils

  • Treatment:

systemic or topical antihistamines or mast cell stabilizers, NSAIDS

  • Patient Education:

identifying allergen and avoiding it, informing patients about effectiveness of antihistamine treatment and why to adhere

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Keratitis

A
  • What is it:

inflammation of the cornea from infection, injury, autoimmune, dry eye, or others

  • Etiology/Pathogens:

“viral: HSV and dendritic ulcer
bacterial: s. aureus, p.aeruginosa, aka corneal ulcer”

  • Epidemiology:

contact lens wearing is a significant indicator, farmers are at high risk, fungal common in developing nations

  • Pathophysiology:

recruitment of leukocytes and macrophages as a response to infiltration of a pathogen

  • Signs:

recent topical corticosteroids, lacrimal duct patency or regurgitation, corneal opacity or infiltrate (round white spot)

  • History/Symptoms:

redness, pain, irritation, photophobia, visual decline, cosmetic blemish, foreign body sensation

  • Evaluation:

fluorescein staining can diagnose epithelial herpes keratitis by presence of dendritic lesions

  • Treatment:

”* opthalmology consultation
* topical antivirals treat herpetic keratitis
*topical bactericidal antibiotics treat bacterial keratitis
*antifungal eyedrops for fungal infections”

  • Patient Education:

using eyeshields when working in agricultural fields

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Corneal ulcer

A
  • What is it:

corneal epithelium defect, potentially vision-threatening, starts as keratitis

  • Etiology/Pathogens:

“bacterial: s. aureus
coagulase-negative staphylococcus, p. aeruginosa (contact lens wearers)
viral: HSV-1, VZV, cytomegalovirus
other causes: fungal, protozoan, pythium, autoimmune

  • Epidemiology:

“keratitis is the precursor
contact lense wearers
unilateral usually”

  • Pathophysiology:

“anatomical, mechanical, and antimicrobial defenses
microbes adhere to the surface of the cornea and replicate releasing toxin and lytic enzymes”

  • Signs:

visualization of ulcer, photophobia, conjunctival injection, variable degree of vision loss

  • History/Symptoms:

contact lens use, ocular surgery, ocular trauma, herpes exposure, work exposure, use of immunosuppressors, pain, redness, foreign body sensation, photophobia, tearing, watery discharge, swelling, blurred vision, gritty feeling

  • Evaluation:

slit-lamp examination can help distinguish type

  • Treatment:

”* culture collected by an opthalmologist
* can do a bacterial culture, fungal, viral or protozoan
*opthalmologic emergency”

  • Patient Education:

advise patients on healthy contact lens use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pterygium

A
  • What is it:

ocular surface disorder, fibrovascular overgrowth of the subconjunctival tissue that encroaches on the cornea

  • Etiology/Pathogens:

UV exposure, hot and dry weather, wind, dust, genetic predisposition

  • Epidemiology:

those working outside, men more than women, particular geographic region (37 degrees north and south of equator)

  • Pathophysiology:

UV rays cause insufficiency of the limbal stem cells of the cornea and activation of tissue growth factors, can grow (active) or remain static (inactive)

  • Signs:

triangular tissue bilaterally formation on the lateral or medial aspect, erythema or irritation, vision disruption

  • History/Symptoms:

eye irritation, lacrimation, foreign body sensation, difficulty in fitting contact lens, diminuition of vision

  • Evaluation:

“ocular examination
Schirmer’s test for dry eye
refraction to characterize astigmatism”

  • Treatment:

“*artificial tears
*monitoring growth
*surgical excision if growth interrupts vision
*topical vasoconstrictor”

  • Patient Education:

explain chances of recurrence and proper eye protection when in sunlight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Uveitis

A
  • What is it:

inflammation of the uvea (iris, ciliary body, choroid), categorized based on location of the inflammation

  • Etiology/Pathogens:

idiopathic but can be associated with trauma, inflammation, or infection, concurrent symptoms should be analyzed

  • Epidemiology:

can affect people of all ages, anterior uveitis is the most prevalent

  • Pathophysiology:

not well understood, hypothesis that trauma to the eye can cause cell injury or death resulting in inflammatory cytokines

  • Signs:

hypophon, cell and flare, ciliary flush

  • History/Symptoms:

varies by location: pain, blurred vision, floaters, vision loss, synechia

  • Evaluation:

first occurrence my not require laboratory workup, testing for HLA-B27

  • Treatment:

”* eliminating inflammation and pain with steroids and topical cycloplegics
*other meds may be used to treat underlying cause”

  • Patient Education:

explain disease process, complicance with treatment, and follow up, complications, and precautions on worsening symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Iritis

A
  • What is it:

inflammation of the iris, can also coincide with inflammation of the ciliary cody (anterior cyclitis) resulting in iridocyclitis, also known as anterior uveitis

  • Etiology/Pathogens:

“often idiopathic, but may be a result of blunt trauma
nontraumatic iritis is often associated with HLA-B27 systemic diseases such as JRA, UC, etc. or infectious diseases like TB, chlamydia, Lyme’s”

  • Epidemiology:

young and middle-aged people, responsible for 10% of legal blindness

  • Pathophysiology:

non-purulent (non-supperative) or purulent (supperative), irritation of ciliary nerves and muscles causes pain

  • Signs:

slit lamp evaluation gives purple hue, pupillary miosis, cells and flare present on slit beam, iris nodules

  • History/Symptoms:

eye pain, photophobia, redness, tearing, decreased vision

  • Evaluation:

visual acuity, intraocular pressure, slit beam

  • Treatment:

“*topical cycloplegics and topical steroids
*reference to an opthalmologist”

  • Patient Education:

explain ocular pathology, complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Dacryoadenitis

A
  • What is it:

inflammation of the lacrimal gland, inflammation can be due to infectious, or inflammatory sources but can be idiopathic

  • Etiology/Pathogens:

“can be acute or chronic, acute are infectious and typically unilateral, infection often ascends from the conjunctiva, more often viral, pathogen causes are:
Epstein Barr virus, s. aureus, chronic cases are inflammatory”

  • Epidemiology:

less common than dacryocystitis, acute is most common in children and young adults,

  • Pathophysiology:

gland can become blocked and buildup causes inflammation and swelling

  • Signs:

erythema and tenderness over the supertemporal orbit with enlargement of the gland, S curve of the eyelid margin, discharge from lacrimal ducts, swollen preauricular and cervical lymph nodes

  • History/Symptoms:

pain, redness, swelling, tearing, drainage

  • Evaluation:

clinical observation, chronic cases may necessitate CT or MRI of the orbits, can also do bloodwork to determine etiology or culture

  • Treatment:

“*rest and warm compresses for viral causes
*if purulent can use cultures of discharge to determine antibiotic treatment (beware of MRSA)
*corticosteroids will induce shrinkage”

  • Patient Education:

can do massage to induce, monitor for any concerning eye changes, educate on systemic manifestations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Dacryocystitis

A
  • What is it:

infectious obstruction of the nasolacrimal duct, stagnation of tears in the lacrimal sac which inflames

  • Etiology/Pathogens:

can be classified as acute or chronic, and acquired or congenital (dacryostenosis), most common organisms are staphylococcus species and streptococcus species

  • Epidemiology:

congenital is just after birth, other cases in adults older than 40, mostly women, more often in white race

  • Pathophysiology:

obstruction at any level of the nasolacrimal system, stagnation of tears, favorable environment for infectious organisms to propagate

  • Signs:

edema and erythema above the nasolacrimal duct, tearing, mucopurulent discharge

  • History/Symptoms:

tearing, matting, conjunctival injection, decrease in visual acuity, no pain with extraocular movements

  • Evaluation:

clinical observation diagnosis, cultures and gram staining can be done using purulent material expressed via the Crigler massage, more serious cases could do blood cultures

  • Treatment:

“*acute is treated with systemic antibiotics targeting staphylococcal agents (amoxicillin)
*chronic is treated with surgical therapy”

  • Patient Education:

watch for changes in symptoms, or swelling spreading to medial canthal region

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Dacryostenosis

A
  • What is it:

congenital or acquired narrowing of the nasolacrimal duct and subsequent failure of tear draining into the nasal passages

  • Etiology/Pathogens:

anatomical abnormalities or acquired etiologies such as infections, inflammations, medications or damage to the lacrimal system

  • Epidemiology:

congenital occurs in 6% of all newborns, Down syndrome and premature birth increase likelihood as well as C section delivery

  • Pathophysiology:

most often a mechanical obstruction in the distal portion of the nasolacrimal duct

  • Signs:

increased size of the tear meniscus, debris on eyelashes, refluz of tears of mucoid discharge onto the eye, minimal erythema of the lower eyelid

  • History/Symptoms:

“epiphora, mattering, stress epiphora
NO fever, irritability, conjunctivitis”

  • Evaluation:

“clinical diagnosis in clinic
fluorescein dye dissapearance test, dacryocystography, dacryoscintigraphy”

  • Treatment:

“*massaging the duct (Crigler lacrimal sac compression)
*if the problem persists past 6-10 months send to opthalmologist
*lacrimal duct probing or nasolacrimal intubation”

  • Patient Education:

educate patients about the normal drainage process, if problem doesn’t resolve consider imaging and procedures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Keratoconjunctivitis sicca

A
  • What is it:

chronic dryness of the cornea and conjunctiva from insufficienct tear production or tear evaporation

  • Etiology/Pathogens:

commonly caused by autoimmune disease (Sjogren’s syndrome, rheumatoid arthritis), aging, medications (antihistamines, beta-blockers), and environmental factors

  • Epidemiology:

women over 40, individuals with autoimmune conditions, prolonged screen exposure

  • Pathophysiology:

aqueous tear deficiency, evaporative dry eye, meibomian gland dysfunction, hyperosmolarity of the tear film

  • Signs:

normal visual acuity, tear production less than 5 mm in 5 minutes, reduced tear film breakup time, punctate epithelial erosions visible via fluorescein staining

  • History/Symptoms:

dryness, burning, foreign body sensation, blurred vision, gritty sensation, epiphora, excessive blinking

  • Evaluation:

“clinical symptoms and tear function tests
Schirmer’s test - measures volume of tear production
tear breakup test
slit lamp examination
fluorscein staining”

  • Treatment:

“*artificial tears
*opthalmic lubricating ointment for nightime use”

  • Patient Education:

advise the patient about environmental and behavioral modifications that can be performed to reduce DED

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hordeolum

A
  • What is it:

painful, acute injection of the upper or lower eyelid

  • Etiology/Pathogens:

acute bacterial infection of, usually, s. aureus on the eyelid margin due to abscess formation on the glands of the eyelashes, can progress to a chalazion

  • Epidemiology:

common across age and demographics, chronic conditions may increase risk (dermatitis, diabetes, high serum lipids)

  • Pathophysiology:

external hordeolum are infections of the Zeis and Moll glands, can also happen in meibomian glands

  • Signs:

hot to the touch, diffuse tenderness, erythema,

  • History/Symptoms:

burning and tender swelling of one eyelid, tearing, photophobia

  • Evaluation:

no tests necessary, colonizations can be done but are not necessary

  • Treatment:

“*resolution typically occurs spontaneously within a week
*can hasten healing with warm compresses or erythromycin ointment”

  • Patient Education:

explain warm compresses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Blepharitis

A
  • What is it:

inflammation of eyelids usually bilaterally caused by dysfunctional meibomian gland or staph infection, more common to be chronic

  • Etiology/Pathogens:

acute can be ulcerative (bacterial staphylococcal, viral HSV or VZV) or nonulcerative (allergic), anterior is an infectious disease process and rosacea, meibomian gland dysfunction causes posterior

  • Epidemiology:

women over 40, individuals with autoimmune conditions, prolonged screen exposure

  • Pathophysiology:

multifactorial, bacteria, inflammatory skin conditions, parasites

  • Signs:

telangiectasia on outer portion of the eyelid, scaling at base of eyelashes, loss of lashes (madarosis), depigmentation of lashes (poliosis) and misdirection (trichiasis)

  • History/Symptoms:

seborrhea, rosacea, crusty eyelids in the AM, itchy, burning, tearing, blurred vision, foreign body sensation

  • Evaluation:

“clinical evaluation diagnosis
can analyze with a slit lamp to better visualize
can do lid biopsy to exclude carcinoma if chronic”

  • Treatment:

“*eyelid hygiene
*warm, wet compresses
*gentle massage for posterior
*topical antibiotics for flare ups”

  • Patient Education:

explain to the patient proper lid hygiene and the importance of lid hygiene to prevent recurrence

11
Q

Chalazion

A
  • What is it:

chronic sterile lipogranuloma, enlarge slowly and non-tender, deep chalazion is inflammation of a tarsal meibomian gland, superficial chalazion is an inflammation of a Zeis gland

  • Etiology/Pathogens:

inflammation and obstruction of a sebaceous gland in an eyelid

  • Epidemiology:

occur more commonly in adulthood but exact incidence data is not documented

  • Pathophysiology:

form when lipid breakdown products leak into surrounding tissue and incite an inflammatory response, on conjunctival portion of the lid due to location of the meibomian glands

  • Signs:

palpable, non-tender, non-fluctuant, non-erythematous, nodule on the eyelid, less than 1cm, more often on upper lid, cold in temperature

  • History/Symptoms:

“painless eyelid swelling, impaired vision, discomfort, can become inflamed, painful, or infected
NO visual changes, eye pain, fever, limited extraocular movements, facial swelling, injection, discharge”

  • Evaluation:

“clinical diagnosis, eyelid should be everted to examine for internal chalazion
recurrent lesions should be assessed for carcinoma”

  • Treatment:

“*warm compresses 15 min 2-4 times a day
*could use an injectable corticosteroid or incision + curretage for large ones”

  • Patient Education:

hard to prevent, keep up good hygiene

12
Q

Ectropion

A
  • What is it:

outward turning of the eyelid margin, typically on the lower eyelids, can result in eye dryness which may result in other symptoms

  • Etiology/Pathogens:

caused by age-related tissue relaxation, cranial nerve VII palsy (facial), posttraumatic or postsurgical changes

  • Epidemiology:

common in elderly patients, some report as high as 2%

  • Pathophysiology:

muscle and ligament relaxation due to aging, can also be due to scar tissue from surgery or injury

  • Signs:

eversion of the eyelid, typically lower

  • History/Symptoms:

tearing, dry eye, eye rubbing

  • Evaluation:

“evaluate the lower eyelid to identify the ectropion, if present
snap back test to see lid recoil, also examine the orbital area for any other abnormalities”

  • Treatment:

“*artificial tears
*ocular lubricants
*extreme case -> surgery”

  • Patient Education:

advise on uses of artificial tears and ocular lubricants

13
Q

Entropion

A
  • What is it:

inward turning of the eyelid margin resulting in trichiasis (eyelashes growing into eye), can cause corneal and conjunctival damage, more common in lower lid

  • Etiology/Pathogens:

“four types: congenital, involutional, acute spactic, cicatricial
involutional is the most common due to age related relaxation of the canthal tendons, acute spastic has many causes (infection, irritation, inflammation)”

  • Epidemiology:

common in elderly patients, more commonly bilateral, more common in women

  • Pathophysiology:

canthal tendons and tarsal plate weaken with age allowing inversion, also potentially due to tarsal atrophy, also can be due to sustained orbicularis oculi muscle contractions

  • Signs:

eyelid inversion

  • History/Symptoms:

eye redness, pain, swelling, sensitivity to light, sagging of skin around eye, epiphora, ocular irritation, decreased vision

  • Evaluation:

snapback test, distraction test, slit lamp test for eyelid retractor disinsertion, may need to test for infection or autoimmune condition

  • Treatment:

“*artificial tears
*ocular lubricants
*extreme case -> surgery”

  • Patient Education:
14
Q

Papilledema

A
  • What is it:

swelling of the optic disk secondary to increased intracranial pressure as a result of increased CSF in the dural sheath of the optic nerve

  • Etiology/Pathogens:

bilateral but may be unilateral, cause needs to be determined, may be indicative of a larger issue: brain tumor, cerebral trauma, meningitis, dural sinus thrombosis, encephalitis

  • Epidemiology:

overweight, 40s, female

  • Pathophysiology:

the optic nerve is compressed due to the subarachnoid space swelling from increased CSF

  • Signs:

optic disc swelling, flame hemmorhages at advanced stages

  • History/Symptoms:

may be asymptomatic, can also experiences headache, nausea, vomiting, visual field loss,

  • Evaluation:

fundoscopy to observe optic disk, neurologic exam, MRI or CT scan of the head to determine the cause

  • Treatment:

“*treat underlying disorder
*refer to neurology”

  • Patient Education:

explain to patient the necessity of identifying underlying cause

14
Q

Nystagmus

A
  • What is it:

involuntary, rapid, and repetitive movement of the eyes, can be horizontal, vertical, or rotary

  • Etiology/Pathogens:

“Down/upbeat: CNS dysfunction
Vestibular (horizontal): labyrinth or vestibular nerve dysfunction
Gaze-evoked: most common and often benign”

  • Epidemiology:

congenital is diagnosed in infancy, acquired is indicative of a serious medical condition

  • Pathophysiology:

congenital or acquired, due to some abnormal brain or ear apparatus structure impacted and the underlying etiology, pathologic nystagmus results from diseases affecting the cortex, anterior visual tracts, brainstem, cerebellum, and peripheral vestibular apparatus

  • Signs:

involuntary eye movements

  • History/Symptoms:

These movements can reduce vision, affect depth perception, balance, and coordination.

  • Evaluation:

analyze the eye movements to try to identify what type and therefore what issue may be occuring

  • Treatment:

n/a

  • Patient Education:

n/a

15
Q

Optic neuritis

A
  • What is it:

a wide range of conditions that decrease the optimal function of the optic nerve, can be infection, trauma, vascular insufficiency, metastases, toxins, or nutritional deficiencies

  • Etiology/Pathogens:

believed to potentially be related to damage of the optic nerves myelin sheath often first clinical manifestation of systemic demyelination (MS), patient with autoimmune conditions at higher risk, viral infections may induce attacks

  • Epidemiology:

“age 20-40, female, caucasian
often an indicator of multiple sclerosis
use of medication ethambutol (TB med)”

  • Pathophysiology:

CNS inflammation with resultant demyelination to varying degrees depending on causant condition, recurring episodes indicate a propensity toward developing a more generalized disease

  • Signs:

optic disc swelling, unilateral presentation, central scotomas are common, any visual field defect may be found

  • History/Symptoms:

monocular eye pain and vision loss, pain with eye movements, often report previous similar events, impaired color vision (red) , occurs over hours or days, worsening vision with increased body temperature

  • Evaluation:

visual testing, fundoscopy of the optic disc, MRI of the brain, testing for associated conditions

  • Treatment:

“*referral to a neurologist
*methylprednisolone IV”

  • Patient Education:

explain the likelihood of MS and encourage further testing

16
Q
A
  • What is it:
  • Etiology/Pathogens:
  • Epidemiology:
  • Pathophysiology:
  • Signs:
  • History/Symptoms:
  • Evaluation:
  • Treatment:
  • Patient Education:
16
Q
A
  • What is it:
  • Etiology/Pathogens:
  • Epidemiology:
  • Pathophysiology:
  • Signs:
  • History/Symptoms:
  • Evaluation:
  • Treatment:
  • Patient Education:
16
Q
A
  • What is it:
  • Etiology/Pathogens:
  • Epidemiology:
  • Pathophysiology:
  • Signs:
  • History/Symptoms:
  • Evaluation:
  • Treatment:
  • Patient Education:
17
Q
A
  • What is it:
  • Etiology/Pathogens:
  • Epidemiology:
  • Pathophysiology:
  • Signs:
  • History/Symptoms:
  • Evaluation:
  • Treatment:
  • Patient Education:
17
Q
A
  • What is it:
  • Etiology/Pathogens:
  • Epidemiology:
  • Pathophysiology:
  • Signs:
  • History/Symptoms:
  • Evaluation:
  • Treatment:
  • Patient Education:
18
Q
A
  • What is it:
  • Etiology/Pathogens:
  • Epidemiology:
  • Pathophysiology:
  • Signs:
  • History/Symptoms:
  • Evaluation:
  • Treatment:
  • Patient Education:
18
Q
A
  • What is it:
  • Etiology/Pathogens:
  • Epidemiology:
  • Pathophysiology:
  • Signs:
  • History/Symptoms:
  • Evaluation:
  • Treatment:
  • Patient Education:
18
Q
A
  • What is it:
  • Etiology/Pathogens:
  • Epidemiology:
  • Pathophysiology:
  • Signs:
  • History/Symptoms:
  • Evaluation:
  • Treatment:
  • Patient Education:
19
Q
A
  • What is it:
  • Etiology/Pathogens:
  • Epidemiology:
  • Pathophysiology:
  • Signs:
  • History/Symptoms:
  • Evaluation:
  • Treatment:
  • Patient Education:
20
Q
A
  • What is it:
  • Etiology/Pathogens:
  • Epidemiology:
  • Pathophysiology:
  • Signs:
  • History/Symptoms:
  • Evaluation:
  • Treatment:
  • Patient Education:
21
Q
A
  • What is it:
  • Etiology/Pathogens:
  • Epidemiology:
  • Pathophysiology:
  • Signs:
  • History/Symptoms:
  • Evaluation:
  • Treatment:
  • Patient Education:
22
Q
A
  • What is it:
  • Etiology/Pathogens:
  • Epidemiology:
  • Pathophysiology:
  • Signs:
  • History/Symptoms:
  • Evaluation:
  • Treatment:
  • Patient Education:
22
Q
A
  • What is it:
  • Etiology/Pathogens:
  • Epidemiology:
  • Pathophysiology:
  • Signs:
  • History/Symptoms:
  • Evaluation:
  • Treatment:
  • Patient Education:
23
Q
A
  • What is it:
  • Etiology/Pathogens:
  • Epidemiology:
  • Pathophysiology:
  • Signs:
  • History/Symptoms:
  • Evaluation:
  • Treatment:
  • Patient Education:
24
Q
A
  • What is it:
  • Etiology/Pathogens:
  • Epidemiology:
  • Pathophysiology:
  • Signs:
  • History/Symptoms:
  • Evaluation:
  • Treatment:
  • Patient Education:
25
Q
A
  • What is it:
  • Etiology/Pathogens:
  • Epidemiology:
  • Pathophysiology:
  • Signs:
  • History/Symptoms:
  • Evaluation:
  • Treatment:
  • Patient Education:
26
Q
A
  • What is it:
  • Etiology/Pathogens:
  • Epidemiology:
  • Pathophysiology:
  • Signs:
  • History/Symptoms:
  • Evaluation:
  • Treatment:
  • Patient Education:
27
Q
A
  • What is it:
  • Etiology/Pathogens:
  • Epidemiology:
  • Pathophysiology:
  • Signs:
  • History/Symptoms:
  • Evaluation:
  • Treatment:
  • Patient Education: